Locteron is a controlled release interferon alpha that is administered every 2 weeks and has a better side effect  profile than currently available Pegasys (R)  and PEG-Intron .

http://www.marketwire.com/press-release/Biolex-Announces-Presentation-EASL-Interim-Results-From-EMPOWER-Phase-2b-Study-Locteron-1148840.htm

This entry was posted on Thursday, February 11th, 2010 at 12:36 PM and is filed under Research & Development. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.